Back
Astrana Health Quote, Financials, Valuation and Earnings
Sponsored
ASTH
Sponsored
A Silent Invasion of America
Click here to see what you can do to make sure you're not left behind.
Buy
52
ASTH
Astrana Health
Last Price:
39.7400
Seasonality Move:
14.37%
7 Day Trial
ALL ACCESS PASS
$
7
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.Astrana Health Price Quote
$39.7400
-0.1800 (-0.45%)
(Updated: July 5, 2024 at 6:55 PM ET)
Astrana Health Key Stats
Buy
52
Astrana Health (ASTH)
is a Buy
Day range:
$39.6400 - $40.3800
52-week range:
$28.8650 - $45.7126
Dividend yield:
0%
P/E ratio:
30.95
P/S ratio:
1.29
P/B ratio:
2.78%
Volume:
98.3K
Avg. volume:
183.2K
1-year change:
28.69%
Market cap:
$1.8B
Revenue:
$1.4B
EPS:
$1.32
How Much Does Astrana Health Make?
-
How Much Are Astrana Health's Sales Annually?
ASTH Revenues are $1.4B -
How Much Profit Does Astrana Health's Make A Year?
ASTH net income is $60.7M
Is Astrana Health Growing As A Company?
-
What Is Astrana Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.2% -
What Is Astrana Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.11%
Astrana Health Stock Price Performance
-
Did Astrana Health Stock Go Up Last Month?
Astrana Health share price went down by -5.49% last month -
Did ASTH's Share Price Rise Over The Last Year?
ASTH share price rose by 28.69% over the past 1 year
What Is Astrana Health 52-Week High & Low?
-
What Is Astrana Health’s 52-Week High Share Price?
Astrana Health has traded as high as $45.7126 over the past 52 weeks -
What Is Astrana Health’s 52-Week Low Share Price?
Astrana Health has traded as low as $28.8650 over the past 52 weeks
Astrana Health Price To Free Cash Flow
-
Is Astrana Health Stock Overvalued?
Astrana Health is trading at a price to free cash flow ratio of 35.88 -
Is Astrana Health Stock Undervalued?
Astrana Health EV to Free Cash Flow ratio is 31.75 -
What Is Astrana Health’s Price Earnings Growth Ratio?
ASTH PEG ratio is 0.87 -
Is Astrana Health Trading At A Premium To Earnings?
Astrana Health EV to EBIT ratio is 14.50
Is It Risky To Buy Astrana Health?
-
How Much Debt Does Astrana Health Have?
Total long term debt quarterly is $389.2M -
How Much Cash Does Astrana Health Have?
Cash and short term investments quarterly total is $337.3M -
What Is Astrana Health’s Book Value Per Share?
Book value per share is 13.77
Is Astrana Health Cash Flow Positive?
-
What Is ASTH Cash Flow From Operations?
Cash flow from operations (TTM) is $66.5M -
What Is Astrana Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is $116.9M -
What Is Astrana Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$122.5M
Astrana Health Return On Invested Capital
-
Is Management Doing A Good Job?
ASTH return on invested capital is 7.94% -
What Is Astrana Health Return On Assets?
ROA measures how assets are converting to revenues and is 5.94% -
What Is ASTH Return On Equity?
ROE is a measure of profitability and is 11.82%
Astrana Health Earnings Date & Stock Price
-
What Is Astrana Health's Stock Price Today?
A single share of ASTH can be purchased today for 39.9200 -
What Is Astrana Health’s Stock Symbol?
Astrana Health trades on the nasdaq under the ticker symbol: ASTH -
When Is Astrana Health’s Next Earnings Date?
The next quarterly earnings date for Astrana Health is scheduled on August 7, 2024 -
When Is ASTH's next ex-dividend date?
Astrana Health's next ex-dividend date is July 5, 2024 -
How To Buy Astrana Health Stock?
You can buy Astrana Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Astrana Health Competitors
-
Who Are Astrana Health's Competitors?
Below is a list of companies who compete with Astrana Health or are related in some way:
Astrana Health Dividend Yield
Data Unavailable
Astrana Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 10.71% | 120.07% |
Revenue: | 19.9% | -2.29% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 53.1429 |
Upside from Last Price: | 33.12% |